| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| caplacizumab | von willebrand factor | biotech | Successful target | TTD , drugbank , DGIDB | Blood coagulation[MeSHID:D001777] Thrombotic thrombocytopenic purpura acquired[MeSHID:C536901] Acute Coronary Syndrome[MeSHID:D054058] Thrombosis[MeSHID:D013927] Blood Platelets[MeSHID:D001792] Rare Diseases[MeSHID:D035583] Ischemia[MeSHID:D007511] Thrombocytopenia[MeSHID:D013921] Anemia Hemolytic[MeSHID:D000743] Purpura Thrombotic Thrombocytopenic[MeSHID:D011697] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
13.64 | approved,investigational | inhibitor |
| click here to return to the previous page | ||||||||